DOCSLIB.ORG

Central Nervous System Dysfunction As the First Manifestation of Multiple

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Central Nervous System Dysfunction As the First Manifestation of Multiple Bone Marrow Transplantation (2000) 25, 79–83 2000 Macmillan Publishers Ltd All rights reserved 0268–3369/00 $15.00 www.nature.com/bmt Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients B Gordon1, E Lyden2, J Lynch2, S Tarantolo3, ZS Pavletic3, M Bishop3, E Reed3, A Kessinger3 and W Haire3 Departments of 1Pediatrics, 2Preventive and Societal Medicine, and 3Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA Summary: Organ system dysfunction is a frequent complication of hematopoietic stem cell transplantation. Single and multior- Development of CNS dysfunction in the setting of hema- gan dysfunction may be due to the culmination of an uncon- topoietic stem cell transplant (HSCT) has been pre- trolled inflammatory response to some initial event, viously shown to predict for subsequent second organ mediated by an as yet incompletely understood interplay of dysfunction and death. In this paper, we describe the cytokines, complement, and the coagulation system. In the characteristics of this isolated CNS dysfunction, and its setting of acutely ill non-transplant patients, this has been relationship to multiple organ dysfunction syndrome termed the systemic inflammatory response syndrome.1 (MODS) after HSCT. Twenty-one of 186 patients This syndrome has been well described in patients with undergoing HSCT developed CNS dysfunction as their trauma or severe infection,1–3 but has only recently been first organ dysfunction a mean of 22.8 ± 0.9 days after recognized in patients undergoing HSCT. the start of the preparative regimen. Compared with The occurrence of single organ system dysfunction in 137 patients who developed no organ dysfunction, the post-transplant period has been shown to predict for patients presenting with CNS dysfunction were more subsequent development of multiple organ dysfunction and likely to have undergone allogeneic HSCT (P = 0.001) death. McDonald and coworkers4 showed that development and to have received a total body irradiation-based regi- of hepatic dysfunction, manifesting as veno-occlusive dis- men (P = 0.001), and were less likely to have been trans- ease, predicted for subsequent multiorgan failure and death. planted for lymphoma (P = 0.008). Patients who We have previously shown that development of pulmonary developed CNS dysfunction were more likely to die than dysfunction predicted for and preceded multiorgan failure those with no organ dysfunction (P Ͻ 0.001). Of the 21 in another group of patients undergoing HSCT.5 Although patients who developed CNS dysfunction, 48% resolved the first organ involved differed in these two reports, the their dysfunction by a mean of 4.6 days later without combined data support the contention that single organ progression to second organ dysfunction, and 90% of dysfunction is not a disorder confined to one organ, but a these patients survived to day 100. Fifty-two percent of manifestation of a more generalized abnormality. patients with CNS dysfunction progressed to second The latter study also assessed the development of CNS organ dysfunction (pulmonary or hepatic) a mean of 5.5 dysfunction, defined as lethargy or confusion, and showed days later, and only 36% survived to day 100 (P = 0.02). a significant correlation between CNS dysfunction and sub- The patients who progressed to second organ dysfunc- sequent second organ dysfunction and death. As part of tion and those who did not were not different in terms a larger study of organ dysfunction following HSCT, we of type of HSCT (allogeneic vs autologous), stem cell identified a group of patients who developed evidence of source (blood vs bone marrow), age, diagnosis or pre- mental status changes in the absence of any other detectable parative regimen. Development of CNS dysfunction in organ dysfunction. Herein, we describe the characteristics the setting of HSCT, as with other organ dysfunctions of this isolated CNS dysfunction, and its relationship to (such as hepatic veno-occlusive disease), probably rep- multiple organ dysfunction syndrome (MODS) after HSCT. resents an early manifestation of a systemic disorder predisposing for MODS, increasing the risk of trans- plant-related mortality. Early systemic therapies Methods directed at modulating this systemic disorder are prob- ably indicated. Bone Marrow Transplantation (2000) 25, Patients 79–83. Keywords: CNS dysfunction; multiple organ dysfunc- This analysis was based on 186 adult patients (mean age tion; stem cell transplant 44.0 years, range 19–70) undergoing autologous or allo- geneic HSCT at the University of Nebraska Medical Center over an 18-month period between December 1995 and May Correspondence: Dr B Gordon, Department of Pediatrics, University of Nebraska Medical Center, 982168 Nebraska Medical Center, Omaha, NE 1997. Patient characteristics are shown in Table 1. Various 68198-2168, USA preparative regimens were used, based on diagnosis. How- Received 7 May 1999; accepted 27 July 1999 ever, 180 of 186 patients (97%) were prepared with one of CNS dysfunction and MODS after HSCT B Gordon et al 80 Table 1 Demographic information at least 2 h on the same day. (3) Renal dysfunction: defined as serum creatinine greater than 1.5 mg/dl. (4) Hepatic Type of transplant (%) veno-occlusive disease: defined as either of two clinical and Autologous bone marrow 33 (18) laboratory syndromes: (a) bilirubin Ͼ1.8 mg/dl and Autologous peripheral blood cell 99 (53) Allogeneic bone marrow 19 (10) abdominal pain and weight gain of more than 5% over 7 Allogeneic peripheral blood cell 35 (19) admission weight; or (b) bilirubin Ͼ2.0 mg/dl and two of hepatomegaly, ascites, and weight gain of more than 5% Allogeneic 54 (29) 8 Autologous 132 (71) over admission weight. Bone marrow 52 (28) Peripheral blood cell 134 (72) Statistics Disease (%) All data are expressed as means ± standard error. Analysis Non-Hodgkin’s lymphoma 68 (37) of variance (ANOVA) and t-tests were used to compare Hodgkin’s disease 11 (6) continuous variables. Fisher’s exact test was used to com- Breast carcinoma 51 (27) р Acute leukemia 20 (11) pare categorical variables. A P value of 0.05 was Chronic myeloid leukemia 19 (10) considered significant. Other 17 (9) Results six different regimens (Table 2). The preparative regimen Incidence and predisposing factors for CNS dysfunction included total body irradiation in 58 cases (31%). For the purpose of the analysis of medication intake, Of the 186 patients studied, 21 (11%) developed CNS dys- patients who developed CNS dysfunction as their first function as their first organ dysfunction, and 28 developed organ dysfunction were matched to control patients without a different organ dysfunction (either pulmonary or hepatic) organ dysfunction, based on HSCT type, diagnosis, and as their first organ dysfunction. Time to development of days post-HSCT. Total daily dose and total daily dose per first organ dysfunction was no different between these two ± body weight were recorded for CNS active medications groups (mean 22.8 0.9 days after start of the preparative ± (morphine, meperidine, diphenhydramine, lorazepam) on regimen for CNS dysfunction vs 21.1 1.1 days for other the day prior to, and the day of development of CNS dysfunctions). One hundred and thirty-seven patients dysfunction. developed no organ dysfunction (Figure 1). Comparing the 21 patients who developed CNS dysfunc- tion as their first organ dysfunction with the 137 patients Transplant practices who developed no organ dysfunction, patients developing Because adverse events occurring after HSCT were postu- CNS dysfunction as the first dysfunction were more likely = lated to be related to the toxicity of the preparative regi- to have undergone allogeneic HSCT (P 0.001) and to mens, the first day of the preparative regimen is considered have been prepared with a TBI-based preparative regimen = day 1 in this report. (P 0.001), and were less likely to be undergoing HSCT for lymphoma (P = 0.008). Development of CNS dysfunc- tion as a first dysfunction did not correlate with age or with Adverse events the source of stem cells (bone marrow vs peripheral blood). Patients were monitored daily, beginning on the first day of In a multivariate analysis utilizing the same factors, allo- the preparative regimen, for the following adverse clinical geneic stem cell source was the only statistically significant events: (1) Central nervous system (CNS) dysfunction: predictor of CNS dysfunction. Patients undergoing allogeic defined by decrease in Folstein mini-mental status exam6 by greater than four points from the baseline. Since inter- 186 Patients observer variability was ±2 points, this range approached 2 standard deviations. (2) Pulmonary dysfunction: defined by the presence of hypoxia (oxygen saturation of less than no organ dfxn CNS dfxn as other dfxn as 90% using finger oximetry) on two occasions separated by n = 137 1st organ dfxn 1st organ dfxn (22.8 ± 0.9 days) (21.1 ± 1.1 days) n = 21 n = 28 Table 2 Preparative regimens progressed to no 2nd BEAC 50 (27%) 2nd organ dfxn organ dfxn CY/thioTEPA 18 (10%) n = 11 n = 10 CY/thioTEPA/HU 35 (19%) CVB 19 (10%) other non-TBI 6 (3%) alive day 100 alive day 100 alive day 100 alive day 100 n = 4 n = 7 n = 9 n = 1 CY/TBI 34 (18%) CY/VP16/TBI 24 (13%) Figure 1 Distribution and outcome of 186 patients undergoing HSCT, with regard to development of CNS dysfunction as first organ dysfunction. Bone Marrow Transplantation CNS dysfunction and MODS after HSCT B Gordon et al 81 HSCT were more likely to develop CNS dysfunction (P dysfunction 10 patients (48%) resolved their dysfunction a value = 0.0013, odds ratio = 4.83 with confidence interval mean of 4.6 ± 5.8 days (range 1–21) later without pro- of 1.86 to 12.50). gression to second dysfunction. 90% of these patients sur- Patients who developed CNS dysfunction as their first vived to day 100.
Load more

Recommended publications
  • Multiple Organ Dysfunction Syndrome Timothy G. Buchman, Ph.D., MD
    Physiologic Failure: Multiple Organ Dysfunction Syndrome Timothy G. Buchman, Ph.D., M.D. Edison Professor of Surgery Professor of Anesthesiology and of Medicine Washington University School of Medicine St. Louis, Missouri 63110 [email protected] Acknowledgement: This work was supported, in part, by award GM48095 from the National Institutes of Health 2 Buchman Humans, like other life forms, can be viewed as thermodynamically open systems that continuously consume energy to maintain stability in the internal milieu in the face of ongoing environmental stress. In contrast to simple unicellular life forms such as bacteria, higher life forms must maintain stability not only in individual cells but also for the organism as a whole. To this end, a collection of physiologic systems evolved to process foodstuffs; to acquire oxygen and dispose of gaseous waste; to eliminate excess fluid and soluble toxins; and to perform other tasks. These systems—labeled respiratory, circulatory, digestive, neurological, and so on—share several features. • Physiological systems are spatially distributed. Food has to get from mouth to anus. Urine is made in the kidneys but has to exit the urethra. Blood may be pumped by the heart but has to reach the great toe. • Physiologic systems are generally spacefilling and structurally fractal. Each cell has demand for nutrients; each cell excretes waste. Information has to travel from the brain throughout the body. While not every physiologic system is self-similar at all levels of granularity, there is typically a nested architecture that facilitates function: microvillus to villus to intestinal mucosa; alveolus to alveolar unit to bronchial segment; capillary to arteriole to artery.
    [Show full text]
  • Sepsis-3 Definitions. What Are They, and How Should We Use Them?
    Sepsis-3 definitions. What are they, and how should we use them? William T. Browne, MD, FCCM October 28, 2016 ACCP/SCCM Consensus Definitions • SIRS (Systemic Inflammatory Response Syndrome) – Temperature > 38° C or < 36° C – Heart rate > 90 – Respiratory rate > 20 or pCO2 < 32 mm Hg – WBC > 12,000 or < 4,000 or > 10% bands • Any two of the criteria needed for SIRS diagnosis ACCP/SCCM Consensus Definitions • Sepsis – Must have diagnosis of SIRS – Clinical evidence of infection • bacteremia • infiltrate on CXR • abscess on imaging study ACCP/SCCM Consensus Definitions • Severe sepsis – must have diagnosis of sepsis – evidence of organ dysfunction • Organ dysfunction – increase in BUN/creatinine – elevated LFTs – hypoxia – elevated serum lactate ACCP/SCCM Consensus Definitions • Septic shock – must have findings of severe sepsis – hypotension after adequate fluid resuscitation – systolic BP 40 mm Hg below baseline – may not have hypotension if receiving pressor agents Was this a useful bedside tool? Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection Under these new definitions Sepsis(new) = Severe Sepsis(old) Key concepts of sepsis (1) • Sepsis is the primary cause of death from infection, especially if not recognized and treated promptly. Its recognition mandates urgent attention • Sepsis is a syndrome shaped by pathogen factors and host factors (eg, sex, race and other genetic determinants, age, comorbidities, environment) with characteristics that evolve over time. What differentiates sepsis from infection is an aberrant or dysregulated host response and the presence of organ dysfunction. Key concepts of sepsis (2) • Sepsis-induced organ dysfunction may be occult; therefore, its presence should be considered in any patient presenting with infection.
    [Show full text]
  • Cardiorenal Syndromes Presentation
    Outline Cardiorenal Syndromes: New ° Definitions Insights into Combined Heart and Kidney Failure ° Complex, bidirectional pathogenesis ° Novel diagnostic targets Peter A. McCullough, MD, MPH ° Therapy FACC, FACP, FAHA, FCCP, FNKF ° Putting it all together History Outline •1913: Sir Thomas Lewis gave a clinical lecture on paroxysmal dyspnoea in cardiocardio--renalrenal patients with special reference to “cardiac” and “uremic” asthma •1951: the term cardiorenal syndromes (CRS) was coined by Ledoux [i] •1997 to present: Schrier in multiple papers summarized the impact of salt and ° Definitions water retention combined with neurohormonal activation in the pathogenesis of CRS. [ii] [iii] [iv] ° Complex, bidirectional pathogenesis •2003: Brammah and colleagues pointed out that treatment of bilateral renal arterial disease could result in improvement of both heart and kidney function. [v] •2005: Braam demonstrated in animals that organ dysfunction in one system ° Novel diagnostic targets influences that in the other. [vi] •2008: Ronco and colleagues proposed five distinct CRS according to the temporal sequence of organ injury and failure as well as the clinical context. [vii] ° Therapy •2008: Acute Dialysis Quality Initiative (ADQI) involving nephrology, critical care, cardiac surgery, and cardiology was convened. [viii] ° Putting it all together •2011: Karger launches “Cardiorenal Medicine” James Sowers, MD, Editor •2012: ADQI conducted a second consensus conference to review the spectrum of pathophysiologic mechanisms involved in CRS [i] University College Hospital, London, November 12th, 1913. BMJ 2: 1417–1420. Ledoux P. [Cardiorenal syndrome]. Avenir Med. 1951 Oct;48(8):149-53. [ii] Blair JE, Manuchehry A, Chana A, Rossi J, Schrier RW, Burnett JC, Gheorghiade M. Prognostic markers in heart failure-congestion, neurohormones, and the cardiorenal syndrome.
    [Show full text]
  • COVID-19 Recommendations for Health Care Workers (PDF)
    MINNESOTA DEPARTMENT OF HEALTH COVID-19 Recommendations for Health Care Workers 8 / 6 /2021 This guidance was updated on August 6, 2021, to include: . All health care workers, regardless of vaccination status, should be tested for SARS-CoV-2 when symptomatic, after a higher-risk exposure, and when working in a facility experiencing an outbreak. Post-exposure testing should occur immediately and at day 3–5 after exposure. Testing of HCW for COVID-19 Health care workers (HCW) should not work while sick, even if presenting with mild signs or symptoms. HCW with fever and/or respiratory symptoms that are concerning for COVID-19 should be tested for SARS-CoV-2 as soon as possible. HCW who have had unprotected exposure to a person with confirmed COVID-19 but remain asymptomatic should be tested immediately and 3–5 days following the date of exposure at a minimum. Specific routine staff testing is required or recommended by federal and/or state guidelines in skilled nursing or assisted living facilities. Please refer to the following guidance for detailed testing recommendations, which have been updated to discuss recommendations for vaccinated HCWs: . COVID-19 Testing Recommendations for Long-term Care Facilities (www.health.state.mn.us/diseases/coronavirus/hcp/ltctestrec.pdf) HCW with exposure to COVID-19 MDH and health care organizations cooperate to identify, manage, and monitor HCW who have experienced a high-risk (unprotected) exposure to a patient, resident, co-worker, or household/social contact with confirmed COVID-19. Most HCW who have had a high-risk exposure are identified through occupational tracking of personal protective equipment (PPE) breaches and/or contact tracing and assessment of PPE worn while in contact with a COVID-19 positive patient, resident, or co-worker.
    [Show full text]
  • Acute-On-Chronic Liver Failure: an Update Gut: First Published As 10.1136/Gutjnl-2016-312670 on 4 January 2017
    Gut Online First, published on January 4, 2017 as 10.1136/gutjnl-2016-312670 Recent advances in clinical practice Acute-on-chronic liver failure: an update Gut: first published as 10.1136/gutjnl-2016-312670 on 4 January 2017. Downloaded from Ruben Hernaez,1 Elsa Solà,2,3,4 Richard Moreau,5,6,7,8,9 Pere Ginès2,3,4 1Section of Gastroenterology ABSTRACT extrahepatic organ failure (OF) associated with and Hepatology, Department Acute-on-chronic liver failure (ACLF) is a syndrome short-term mortality. The current narrative review of Medicine, Baylor College of Medicine and Michael characterised by acute decompensation of chronic liver will provide insights on the current understanding E. DeBakey Veterans Affairs disease associated with organ failures and high short- of ACLF with emphasis on established definitions, Medical Center, Houston, term mortality. Alcohol and chronic viral hepatitis are the epidemiology, pathophysiology and treatment/man- Texas, USA – 2 most common underlying liver diseases. Up to 40% agement options. Liver Unit, Hospital Clinic de 50% of the cases of ACLF have no identifiable trigger; Barcelona, Universitat de Barcelona, Barcelona, Spain in the remaining patients, sepsis, active alcoholism and Heterogeneity of definitions 3 ’ Institut d Investigacions relapse of chronic viral hepatitis are the most common ACLF is a syndrome characterised by acute and Biomediques August Pi i reported precipitating factors. An excessive systemic severe hepatic abnormalities resulting from differ- Sunyer (IDIBAPS), Barcelona, inflammatory response seems to play a crucial role in the Spain ent types of insults, in patients with underlying 4Centro d’Investigaciones development of ACLF. Using a liver-adapted sequential chronic liver disease or cirrhosis but, in contrast to Biomedicas en Red, organ assessment failure score, it is possible to triage decompensated cirrhosis, has a high short-term enfermedades Hepaticas y and prognosticate the outcome of patients with ACLF.
    [Show full text]
  • Role of Kidney Injury in Sepsis Kent Doi
    Doi Journal of Intensive Care (2016) 4:17 DOI 10.1186/s40560-016-0146-3 REVIEW Open Access Role of kidney injury in sepsis Kent Doi Abstract Kidney injury, including acute kidney injury (AKI) and chronic kidney disease (CKD), has become very common in critically ill patients treated in ICUs. Many epidemiological studies have revealed significant associations of AKI and CKD with poor outcomes of high mortality and medical costs. Although many basic studies have clarified the possible mechanisms of sepsis and septic AKI, translation of the obtained findings to clinical settings has not been successful to date. No specific drug against human sepsis or AKI is currently available. Remarkable progress of dialysis techniques such as continuous renal replacement therapy (CRRT) has enabled control of “uremia” in hemodynamically unstable patients; however, dialysis-requiring septic AKI patients are still showing unacceptably high mortality of 60–80 %. Therefore, further investigations must be conducted to improve the outcome of sepsis and septic AKI. A possible target will be remote organ injury caused by AKI. Recent basic studies have identified interleukin-6 and high mobility group box 1 (HMGB1) as important mediators for acute lung injury induced by AKI. Another target is the disease pathway that is amplified by pre-existing CKD. Vascular endothelial growth factor and HMGB1 elevations in sepsis were demonstrated to be amplified by CKD in CKD-sepsis animal models. Understanding the role of kidney injury as an amplifier in sepsis and multiple organ failure might support the identification of new drug targets for sepsis and septic AKI. Keywords: Sepsis, Acute kidney injury, Chronic kidney disease, Lung injury, High mobility group box 1 Introduction ICUs is also increasing.
    [Show full text]
  • Multiple Organ Dysfunction in Children Mechanically Ventilated
    Saritha Pediatric Critical Care Medicine Multiple Organ Dysfunction in Children Mechanically 10.1097/PCC.0000000000001091 Ventilated for Acute Respiratory Failure* 1529-7535 Scott L. Weiss, MD, MSCE1; Lisa A. Asaro, MS2; Heidi R. Flori, MD3; Geoffrey L. Allen, MD4; Pediatr Crit Care Med David Wypij, PhD2,5,6; Martha A. Q. Curley, PhD, RN7,8; for the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) Study Investigators Weiss et al *See also p. 383. Objectives: The impact of extrapulmonary organ dysfunction, inde- 1Department of Anesthesiology and Critical Care, The Children’s Hospital pendent from sepsis and lung injury severity, on outcomes in pedi- of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. atric acute respiratory failure is unclear. We sought to determine the 2Department of Cardiology, Boston Children’s Hospital, Boston, MA. frequency, timing, and risk factors for extrapulmonary organ dysfunc- 3Division of Pediatric Critical Care, C.S. Mott Children’s Hospital, Univer- tion and the independent association of multiple organ dysfunction sity of Michigan, Ann Arbor, MI. syndrome with outcomes in pediatric acute respiratory failure. 4Division of Critical Care, Department of Pediatrics, Children’s Mercy Hos- Design: Secondary observational analysis of the Randomized Evalu- pitals and Clinics, Kansas City, MO. ation of Sedation Titration for Respiratory Failure cluster-random- 5Department of Biostatistics, Harvard T.H. Chan School of Public Health, ized prospective clinical trial conducted between 2009 and 2013. Boston, MA. Setting: Thirty-one academic PICUs in the United States. 6Department of Pediatrics, Harvard Medical School, Boston, MA. Patients: Two thousand four hundred forty-nine children mechani- 7School of Nursing, University of Pennsylvania, Philadelphia, PA.
    [Show full text]
  • Detrimental Cross-Talk Between Sepsis and Acute Kidney Injury
    Dellepiane et al. Critical Care (2016) 20:61 DOI 10.1186/s13054-016-1219-3 REVIEW Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies Sergio Dellepiane1†, Marita Marengo2† and Vincenzo Cantaluppi3*† review the recent findings on the detrimental cross‐talk Abstract between sepsis and AKI and the identification of new, This article is one of ten reviews selected from the early biomarkers and targeted therapies aimed at im- Annual Update in Intensive Care and Emergency proving the outcome of these critically ill patients. medicine 2016. Other selected articles can be found online at http://www.biomedcentral.com/collections/ New pathogenic mechanisms of sepsis‐associated annualupdate2016. Further information about the aki: the ‘liaison dangereuse’ revisited Annual Update in Intensive Care and Emergency Major advances have been made in our understanding of Medicine is available from http://www.springer.com/ the detrimental connection between the systemic inflam- series/8901. matory response to infection and the acute loss of kid- ney function with consequent improvements in clinical practice. In particular, recent findings have challenged Background the dogma that in the course of severe sepsis and septic Acute kidney injury (AKI) complicates about 3–50 % of shock, AKI is merely a consequence of ischemic damage hospital admissions [1] depending on patient comorbidi- due to tissue hypoperfusion (Fig. 1). ties and on medical procedures performed during the stay. The greatest incidence of AKI is observed in the in- tensive care unit (ICU): indeed, critically ill patients with Renal overflow rather than hypoperfusion hospital‐acquired AKI have a greater in‐hospital mortal- According to old theories, tissue hypoperfusion associ- ity (30–70 %) and a more than double risk of severe ated with sepsis causes renal ischemia and consequently adverse outcomes even 5 years after discharge, including acute tubular necrosis.
    [Show full text]
  • Neurological Sequelae of Sepsis: I) Septic Encephalopathy
    2 The Open Critical Care Medicine Journal, 2011, 4, 2-7 Open Access Neurological Sequelae of Sepsis: I) Septic Encephalopathy Thomas M. Ringer*,1, Hubertus Axer1,2, Bernd F.M. Romeike3, Jan Zinke1,2, Frank Brunkhorst2,4, Otto W. Witte1,2 and Albrecht Günther1,2 1Hans Berger Clinic for Neurology, Jena University Hospital, Friedrich-Schiller-University, Erlanger Allee 101, D- 07747 Jena, Germany 2CSCC – Center for Sepsis Control and Care, Jena University Hospital, Friedrich-Schiller-University, Erlanger Allee 101, D-07747 Jena, Germany 3Department of Neuropathology, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07747 Jena, Germany 4Paul-Martini-Clinical Sepsis Research Unit, Jena University Hospital, Friedrich-Schiller-University, Erlanger Allee 101, D-07747 Jena, Germany Abstract: Septic encephalopathy (SE) or sepsis-associated delirium is the most common encephalopathy in ICU patients. It is defined by brain dysfunction due to systemic inflammatory response syndrome and extracranial infection. Clinically, acute impairment in level of consciousness and confusion are primarily defining symptoms. Precise clinical evaluation of brain function is crucial, although the necessary diagnostic tools are limited and require further verification in clinical studies. Therefore, SE is often underestimated and not frequently diagnosed. This review gives an overview of clinical features, epidemiological data, pathophysiological processes, imaging and neuropathological findings as well as diagnostic and therapeutic approaches in SE patients
    [Show full text]
  • Acute Kidney Injury and Organ Dysfunction: What Is the Role of Uremic Toxins?
    toxins Review Acute Kidney Injury and Organ Dysfunction: What Is the Role of Uremic Toxins? Jesús Iván Lara-Prado 1 , Fabiola Pazos-Pérez 2,* , Carlos Enrique Méndez-Landa 3, Dulce Paola Grajales-García 1, José Alfredo Feria-Ramírez 4, Juan José Salazar-González 5, Mario Cruz-Romero 2 and Alejandro Treviño-Becerra 6 1 Department of Nephrology, General Hospital No. 27, Mexican Social Security Institute, Mexico City 06900, Mexico; [email protected] (J.I.L.-P.); [email protected] (D.P.G.-G.) 2 Department of Nephrology, Specialties Hospital, National Medical Center “21st Century”, Mexican Social Security Institute, Mexico City 06720, Mexico; [email protected] 3 Department of Nephrology, General Hospital No. 48, Mexican Social Security Institute, Mexico City 02750, Mexico; [email protected] 4 Department of Nephrology, General Hospital No. 29, Mexican Social Security Institute, Mexico City 07910, Mexico; [email protected] 5 Department of Nephrology, Regional Hospital No. 1, Mexican Social Security Institute, Mexico City 03100, Mexico; [email protected] 6 National Academy of Medicine, Mexico City 06720, Mexico; [email protected] * Correspondence: [email protected]; Tel.: +52-55-2699-1941 Abstract: Acute kidney injury (AKI), defined as an abrupt increase in serum creatinine, a reduced urinary output, or both, is experiencing considerable evolution in terms of our understanding of the pathophysiological mechanisms and its impact on other organs. Oxidative stress and reactive oxygen species (ROS) are main contributors to organ dysfunction in AKI, but they are not alone. The precise mechanisms behind multi-organ dysfunction are not yet fully accounted for.
    [Show full text]
  • Decreased Fluid Volume to Reduce Organ Damage: a New Approach To
    Resuscitation (2007) 72, 371—378 CLINICAL PAPER Decreased fluid volume to reduce organ damage: A new approach to burn shock resuscitation? A preliminary studyଝ S. Arlati ∗, E. Storti, V. Pradella, L. Bucci, A. Vitolo, M. Pulici Intensive Care Unit ‘‘G. Bozza’’, Niguarda Ca-Granda` Hospital, Piazza Ospedale Maggiore 3, 20162 Milan, Italy Received 28 March 2006; received in revised form 23 June 2006; accepted 14 July 2006 KEYWORDS Summary Burn injury; Objective: To evaluate the impact of decreased fluid resuscitation on multiple- Shock; organ dysfunction after severe burns. This approach was referred to as ‘‘permissive Resuscitation; hypovolaemia’’. Fluid therapy; Methods: Two cohorts of patients with burns >20% BSA without associated injuries Haemodynamics and admitted to ICU within 6 h from the thermal injury were compared. Patients were matched for both age and burn severity. The multiple-organ dysfunction score (MODS) by Marshall was calculated for 10 days after ICU admission. Permissive hypo- volaemia was administered by a haemodynamic-oriented approach throughout the first 24-h period. Haemodynamic variables, arterial blood lactates and net fluid balance were obtained throughout the first 48 h. Results: Twenty-four patients were enrolled: twelve of them received the Parkland Formula while twelve were resuscitated according to the permissive hypo- volaemic approach. Permissive hypovolaemia allowed for less volume infusion (3.2 ± 0.7 ml/kg/% burn versus 4.6 ± 0.3 ml/kg/% burn; P < 0.001), a reduced posi- tive fluid balance (+7.5 ± 5.4 l/day versus +12 ± 4.7 l/day; P < 0.05) and significantly lesser MODS Score values (P = 0.003) than the Parkland Formula.
    [Show full text]
  • Multi-Organ Dysfunction in Neonates with Hypoxic-Ischemic
    Med. J. Cairo Univ., Vol. 78, No. 1, December 461-467, 2010 www.medicaljournalofcairouniversity.com Multi-Organ Dysfunction in Neonates with Hypoxic-Ischemic Encephalopathy LAILA H. MOHAMMED, M.D.; MAI A .KHAIRY, M.D.; NAGY A. EL-HUSSIENY, M.D.*; MOHAMMED H. ZAAZOU, M.D.* and RAGHDAA M. ALY, M.D.* The Departments of Pediatrics, Faculty of Medicine, Cairo University and Ahmed Maher Teaching Hospital*. Abstract Introduction Perinatal hypoxic-ischemic cerebral injury remains an NEONATAL hypoxic-ischemic encephalopathy important recognized cause of cerebral palsy. Most cases of (HIE), the most common neurologic complication hypoxic-ischemic encephalopathy (HIE) result from injury in the perinatal period, is a major cause of chronic in the prenatal period secondary to intrauterine asphyxia, with disturbance of gas exchange across the placenta. disability in childhood [1] . HIE is termed as neonatal encephalopathy that results from systemic hypox- The aim of this study was to assess the patients of hypoxic- emia and decreased cerebral perfusion leading to ischemic encephalopathy regarding the patterns of each organ/ [2] system dysfunction in relation to the outcome and also assess- ischemia . ment of occurrence of multi-organ/system dysfunction and its relation to outcome and the severity of acidosis. Etiology of perinatal HIE includes those cir- cumstances that can affect the cerebral blood flow Our study included 100 full term neonates diagnosed as in the fetus and neoborn compromising the supply HIE. Data wre collected from patients’ files including full of oxygen to the brain. They may develop antepar- maternal history, detailed neonatal history, general and systemic tum (20%), intrapartum (30%), intrapartum and examination, laboratory studies and the outcome of each one.
    [Show full text]